Stay updated with breaking news from Biontech Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Invitation to the Annual General Meeting 2024 Unique identifier of the event: 2008339965e7ee11b53000505696f23c Ladies and Gentlemen, ...
Victoria Meissner: Thank you. Good morning and afternoon. Thank you for joining us today for BioNTech's Third Quarter 2023 Earnings Call.
06.11.2023 - Positive clinical data updates across multiple drug classes including antibody-drug conjugate (ADC) candidates BNT323/DB-1303, BNT325/DB-1305, CAR-T candidate BNT211, T cell therapy candidate BNT221 and mRNA cancer vaccine candidate BNT116Progress ...
BNTX earnings call for the period ending September 30, 2023.
BNTX earnings call for the period ending June 30, 2023.